Rozbeh Sajadi

Rozbeh Sajadi

Auto-generated profile, based on publicly available information

Rozbeh Sajadi

Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Journal of Substance Use
Verified
Journal Article
Closed access
SKSeyed Hossein Mohaqeqi Kamal
Seyed Hossein Mohaqeqi Kamal
SSSajad Sajadi
Sajad Sajadi
GHGholamreza Ghaedamini Harouni
Gholamreza Ghaedamini Harouni
MBMehdi Basakha
Mehdi Basakha
MNMehdi Noroozi
Mehdi Noroozi
Background: Substance use is significantly more prevalent among the homeless, compared to the general population. However, the risk and protective factors for substance abuse among homeless population have not been well defined. Objectives: We examined risk and protective factors for substance abuse among homeless in Tehran. Methods: A total of 193 homeless people from Tehran were interviewed during the autumn 2015 about substance and alcohol use and other social factors associated with drug use disorders. A binary logistic regression model was used to examine the relationship between substance abuse and a set of predictive variables. Results: Prevalence of drug abuse was 61.14% (95% CI: 55.20, 68.8). The most frequent used drugs were recognized to be: heroin, methamphetamine, and opium with prevalence rates of 51.54%, 36.08%, and 16.49%, respectively. Having a stronger social network and being married were of protective factors, while smoking and having history of incarceration turned out to be the risk factors for substance abuse among Iranian homeless people. Conclusion: Results suggested that risk and protective factors may be substantial mechanisms by which to improve substance abuse consequences and apply better contextualize prevention as well as planning early intervention policies for the homeless men.

Verified
Journal Article
Open access
HMHassan Motamed
Hassan Motamed
AFArash Forouzan
Arash Forouzan
KMKambiz Masoumi
Kambiz Masoumi
RSRozbeh Sajadi
Rozbeh Sajadi
Introduction: Asthma is one of the most common chronic disorders of the respiratory tract. Thus, this study intended to evaluate the clinical effects and the peak flow metric effects of nebulized albuterol with heliox versus albuterol nebulization in acute asthma exacerbation. Material and Methods: In this randomized clinical trial study, 109 patients with acute asthma attacks admitted to the emergency departments (EDs) in *** were enrolled. The patients were divided randomly into two groups: the intervention and control groups. The intervention group was nebulized with heliox (helium/oxygen-70: 30) plus albuterol with a 10 mL/min dose for 20 min three times, which lasted 60 min. The control group received standard treatment (albuterol in combination with oxygen). Results: The results showed that the mean scores of FEV1 and PEFR after 20 min were significantly different in the two groups, as FEV1 scores in the intervention group were 2.76 and 3.01 at 20 and 60 min, respectively, while FEV1 scores in the control group were 1.99 and 2.64, respectively (p < 0.001). In addition, PEFR scores in the intervention group at 20 and 60 min were 299.24 and 310.57, respectively. However, these scores in the control group were 237.98 and 274.56, respectively (p < 0.001). Conclusion: The results showed that the use of heliox in t eating severe asthma attacks could be regarded as a different standard treatment that can lead to significantly better control of asthma attacks in the short term.